AU2003245897A1 - Use of active ingredient mixtures containing tocopherols and extracts of harpagopytum procumbens for producing a medicament for arthritis - Google Patents

Use of active ingredient mixtures containing tocopherols and extracts of harpagopytum procumbens for producing a medicament for arthritis

Info

Publication number
AU2003245897A1
AU2003245897A1 AU2003245897A AU2003245897A AU2003245897A1 AU 2003245897 A1 AU2003245897 A1 AU 2003245897A1 AU 2003245897 A AU2003245897 A AU 2003245897A AU 2003245897 A AU2003245897 A AU 2003245897A AU 2003245897 A1 AU2003245897 A1 AU 2003245897A1
Authority
AU
Australia
Prior art keywords
harpagopytum
procumbens
arthritis
medicament
extracts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003245897A
Inventor
Carmen Arias
Bernd Fabry
Santiago Rull Prous
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cognis Iberia SL
Original Assignee
Cognis Iberia SL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cognis Iberia SL filed Critical Cognis Iberia SL
Publication of AU2003245897A1 publication Critical patent/AU2003245897A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
AU2003245897A 2002-06-08 2003-05-28 Use of active ingredient mixtures containing tocopherols and extracts of harpagopytum procumbens for producing a medicament for arthritis Abandoned AU2003245897A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02012765A EP1371372A1 (en) 2002-06-08 2002-06-08 Use of active substance mixtures containing tocopherols and harpagophytum procumbens extracts for the preparation of a drug against rheumatic arthritis
EP02012765.0 2002-06-08
PCT/EP2003/005596 WO2003103694A1 (en) 2002-06-08 2003-05-28 Use of active ingredient mixtures containing tocopherols and extracts of harpagopytum procumbens for producing a medicament for arthritis

Publications (1)

Publication Number Publication Date
AU2003245897A1 true AU2003245897A1 (en) 2003-12-22

Family

ID=29558310

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003245897A Abandoned AU2003245897A1 (en) 2002-06-08 2003-05-28 Use of active ingredient mixtures containing tocopherols and extracts of harpagopytum procumbens for producing a medicament for arthritis

Country Status (3)

Country Link
EP (1) EP1371372A1 (en)
AU (1) AU2003245897A1 (en)
WO (1) WO2003103694A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2915900B1 (en) * 2007-05-07 2012-08-24 Burgundy NEW PROCESS FOR THE PREPARATION OF PURIFIED EXTRACTS OF HARPAGOPHYTUM PROCUMBENS.
WO2011041542A2 (en) 2009-09-30 2011-04-07 Ultimaxx, Inc. Herbal pain killer compositions
FR2961401B1 (en) * 2010-06-17 2013-04-05 Laetitia Mathez ANTI-INFLAMMATORY COMPOSITION
BR102017003318A2 (en) * 2017-02-17 2018-10-30 Aché Laboratórios Farmacêuticos S.A. compounds, compound production process, enriched extract, active enriched fraction fractions, enriched extract production process, plant biomass selection method for enriched extract production, composition and use for treatment of immune disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2773484B1 (en) * 1998-01-09 2001-03-30 Pierre Moreau NEW COMPOSITIONS WITH SYNERGISTIC EFFECT BETWEEN MICRONUTRIENTS AND SUBSTANCES OF LIVING ORIGIN
IL129102A0 (en) * 1999-03-22 2000-02-17 J P M E D Ltd An emulsion
AU2001275160A1 (en) * 2000-06-01 2001-12-11 Theralife, Inc. Compositions for treating back and leg discomfort containing herbals and/or nutritional supplements and/or minerals and/or vitamins

Also Published As

Publication number Publication date
EP1371372A1 (en) 2003-12-17
WO2003103694A1 (en) 2003-12-18

Similar Documents

Publication Publication Date Title
AU2003222642A1 (en) Aerosol generator for drug formulation and methods of generating aerosol
IL163866A0 (en) 8-Azaprostaglandin derivative compounds and drugs containing the compounds s active ingredient
AU2001241236A1 (en) A therapeutic agent of osteoporosis comprising an active ingredient of quercetinderivatives
IL164699A (en) Derivatives of diketohydrazine compounds and pharmaceutical compositions and medicaments containing the compounds as the active ingredient
EP1250127A4 (en) A method of administering a medicinal aerosol formulation
AU2003256555A1 (en) Controlled delivery of active ingredients and sensory markers
AU2002213357A1 (en) Variant igg3 rituxan r and therapeutic use thereof
EP1471955A4 (en) Aerosol generator for drug formulation
AU2003206118A1 (en) Anti-nausea and anti-vomiting activity of cannabidiol compounds
AU2002354054A1 (en) Spiroheterocyclic derivative compounds and drugs comprising the compounds as the active ingredient
AU2002321199A1 (en) Transdermal therapeutic system (TTS) with fentanyl as active ingredient
AU2001269314A1 (en) Therapeutic and prophylactic use of reduced forms of pharmaceutical compounds
AU2001250901A1 (en) Containers for individual doses of an inhalable pharmaceutical
AU2003211103A1 (en) Intracellular delivery of therapeutic agents
AU2003300469A1 (en) Methods for making pharmaceutical dosage forms containing active cushioning components
AU2003276572A1 (en) Pharmaceutical dosage forms of biguanide-sulfonylurea combinations
AU2003240654A1 (en) Pharmaceutical composition containing oxcarbazepine and having a controlled active substance release
AU2001277738A1 (en) Piperidine derivatives and drugs containing these derivatives as the active ingredient
AU2003302188A1 (en) Method of obtaining a soothing active ingredient, active ingredient and compositions obtained
AU2003245897A1 (en) Use of active ingredient mixtures containing tocopherols and extracts of harpagopytum procumbens for producing a medicament for arthritis
AU2003262229A1 (en) Preventive and/or therapeutic drugs for asthma
AU2003257982A1 (en) Pharmaceutical dosage form capable of maintaining stable dissolution profile upon storage
AU2003289929A1 (en) Transmucosal and transdermal medicaments with an improved active ingredient absorption
EP1581258A4 (en) Pharmaceutical formulation and a method of making same
AU2001274022A1 (en) Use of substituted 1-amino-5-phenylpentane-3-ol and/or 1-amino-6-phenylhexane-3-ol compounds as medicaments

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase